Implications for treating patients with chronic myeloid leukemia and cytogenetic abnormalities with first- or second-generation tyrosine kinase inhibitors.
For more resources and information regarding anticancer targeted therapies: [ Ссылка ]
![](https://i.ytimg.com/vi/yILWp6IbYrc/maxresdefault.jpg)
Implications for treating patients with chronic myeloid leukemia and cytogenetic abnormalities with first- or second-generation tyrosine kinase inhibitors.
For more resources and information regarding anticancer targeted therapies: [ Ссылка ]